-
Dabrafenib
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) Dabrafenib -
Aprocitentan
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) Aprocitentan -
Tirzepatide
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) Tirzepatide Mofuta oa 2 oa lefu la tsoekere, fokotsa boima ba 'mele Eli Lilly Jan.05,2036 -
Semaglutide
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) Semaglutide Mofuta oa 2 oa lefu la tsoekere, ho theola boima ba 'mele Novo Nordisk Dec.05,2031 -
Oteseconazole
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) Oteseconazole Fokotsa sekhahla sa liketsahalo tsa hangata vulvovaginal candidiasis
MycoviaPharmaceuticals Apr.22,2031 -
Finerenone
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) Finerenone Nephropathy ea lefu la tsoekere Bayer Apr.12,2029 -
Capivasertib
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) Capivasertib kankere ea matsoele AstraZeneca Mar.10.2030 -
Resmetirom
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) Resmetirom NASH Roche Sep.12,2026 -
"Darolutamide"
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) "Darolutamide" phekolo ea kankere ea tšoelesa ea senya Bayer La 25 Hlakubele 2033 -
Upadacitinib
Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US) Upadacitinib Dermatitis ea Atopic ABBVIE INC Dec.01,2030
